☰

Sounak Gupta, Ph.D. - Publications

Affiliations: 
2010 Pennsylvania State University, State College, PA, United States 
Tree Info Grants Similar researchers PubMed Report error

35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Mata DA, Yang SR, Ferguson DC, Liu Y, Sharma R, Benhamida JK, Al-Ahmadie HA, Chakravarty D, Solit DB, Tickoo SK, Gupta S, Arcila ME, Ladanyi M, Feldman DR, Reuter VE, et al. RAS/MAPK Pathway Driver Alterations Are Significantly Associated with Oncogenic KIT Mutations in Germ-cell Tumors. Urology. PMID 32721511 DOI: 10.1016/J.Urology.2020.07.027  0.308
2020 Gupta S, Vanderbilt CM, Leibovich BC, Herrera-Hernandez L, Raghunathan A, Sukov WR, Voss JS, Barr Fritcher EG, Reed KA, Lohse CM, Reuter VE, Jimenez RE, Thompson RH, Cheville JC. Secondary Renal Neoplasia Following Chemotherapy or Radiation in Pediatric Patients. Human Pathology. PMID 32681944 DOI: 10.1016/J.Humpath.2020.07.014  0.356
2020 Marcon J, DiNatale RG, Sanchez A, Kotecha RR, Gupta S, Kuo F, Makarov V, Sandhu A, Mano R, Silagy AW, Blum KA, Nassau DE, Benfante NE, Ortiz MV, Carlo MI, et al. Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy number variations as drivers of disease progression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32220885 DOI: 10.1158/1078-0432.Ccr-19-3283  0.362
2020 Gupta S, Inwards CY, Van Dyke DL, Jimenez RE, Cheville JC. Defining Clear Cell Papillary Renal Cell Carcinoma in Routine Clinical Practice. Histopathology. PMID 31989679 DOI: 10.1111/His.14071  0.307
2019 Gupta S, Argani P, Jungbluth AA, Chen YB, Tickoo SK, Fine SW, Gopalan A, Al-Ahmadie HA, Sirintrapun SJ, Sanchez A, Hakimi AA, Mcfarlane T, Salazar PA, Williamson SR, Skala SL, et al. TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations. The American Journal of Surgical Pathology. 43: 1445-1461. PMID 31600176 DOI: 10.1097/Pas.0000000000001307  0.332
2019 Gupta S, Swanson AA, Chen YB, Lopez T, Milosevic D, Kipp BR, Leibovich BC, Thompson RH, Herrera-Hernandez L, Cheville JC, Jimenez RE. Incidence of Succinate Dehydrogenase and Fumarate Hydratase-Deficient Renal Cell Carcinoma Based on Immunohistochemical Screening with SDHA/SDHB and FH/2SC. Human Pathology. PMID 31299266 DOI: 10.1016/J.Humpath.2019.07.004  0.376
2019 Walasek A, Gupta S, Fine S, Russo P. Juxtaglomerular Cell Tumor: A Rare, Curable Cause of Hypertension in a Young Patient. Urology. PMID 31233811 DOI: 10.1016/J.Urology.2019.06.009  0.326
2019 Hau AM, Gupta S, Leivo MZ, Nakashima K, Macias J, Zhou W, Hodge A, Wulfkuhle J, Conkright B, Bhuvaneshwar K, Rao S, Madhavan S, Petricoin EF, Hansel DE. Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by mTORC2 in Bladder Cancer Cells. The American Journal of Pathology. PMID 31199921 DOI: 10.1016/J.Ajpath.2019.05.010  0.302
2019 Gupta S, Sosa CP, Kosari F, Folpe A, Bhinge KN, Yang L, Agahi A, Johnson SH, Frank I, Boorjian SA, Hansel DE, Al-Ahmadie HA, Reuter VE, Vasmatzis G, Jimenez RE, et al. A comparison of adult rhabdomyosarcoma and high grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma. Human Pathology. PMID 30946934 DOI: 10.1016/J.Humpath.2019.03.007  0.334
2019 Blum K, DiNatale R, Sanchez A, Silagy A, Marcon J, Mano R, Gupta S, Tickoo S, Reuter V, Coleman J, Russo P, Hakimi AA. Mp42-14 Sarcomatoid Features In Renal Cell Carcinoma: Rethinking The Stage-Survival Paradigm The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556217.19668.90  0.342
2019 Marcon J, Sanchez A, Gupta S, Natale RGD, Sandhu A, Mano R, Silagy AW, Blum KA, Nassau DE, Motzer RJ, Coleman JA, Russo P, Reuter VE, Hakimi AA, Reznik E. Mp16-15 Comprehensive Analysis Of Oncogenic Events In Translocation Renal Cell Carcinoma The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000555351.44300.3F  0.331
2019 Marcon J, Sanchez A, Gupta S, Di Natale R, Sandhu A, Mano R, Silagy A, Blum K, Nassau D, Motzer R, Coleman J, Russo P, Reuter V, Hakimi A, Reznik E. Comprehensive investigation of the molecular underpinnings of translocation renal cell carcinoma European Urology Supplements. 18: e78-e79. DOI: 10.1016/S1569-9056(19)30060-0  0.336
2018 Gupta S, Sahu D, Bomalaski JS, Frank I, Boorjian SA, Thapa P, Cheville JC, Hansel DE. Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20. Endocrine Pathology. PMID 29453600 DOI: 10.1007/S12022-018-9516-9  0.337
2018 Nassau DE, Sanchez A, Dinatale R, Blum KA, Ghanaat M, Gupta S, Arcila ME, Voss MH, Motzer RJ, Russo P, Coleman J, Reznik E, Reuter V, Hakimi AA. MP28-08 CLINICOPATHOLOGIC AND GENOMIC EVALUATION OF TRANSLOCATION RENAL CELL CARCINOMA Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.908  0.32
2017 Gupta S, Zhang J, Erickson LA. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase. Endocrine Pathology. PMID 28752484 DOI: 10.1007/S12022-017-9494-3  0.307
2017 Gupta S, Zhang J, Milosevic D, Mills JR, Grebe SK, Smith SC, Erickson LA. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127). Endocrine Pathology. PMID 28646318 DOI: 10.1007/S12022-017-9489-0  0.338
2017 Gupta S, Johnson SH, Vasmatzis G, Porath B, Rustin JG, Rao P, Costello BA, Leibovich BC, Thompson RH, Cheville JC, Sukov WR. TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 28338654 DOI: 10.1038/Modpathol.2017.24  0.372
2016 Sahu D, Gupta S, Hau AM, Nakashima K, Leivo MZ, Searles SC, Elson P, Bomalaski JS, Casteel DE, Boss GR, Hansel DE. Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase. The American Journal of Pathology. PMID 27979310 DOI: 10.1016/J.Ajpath.2016.09.004  0.38
2016 Gupta S, Jimenez RE, Folpe AL, Cheville JC. Renal Leiomyoma and Leiomyosarcoma: A Study of 57 Cases. The American Journal of Surgical Pathology. PMID 27276240 DOI: 10.1097/Pas.0000000000000681  0.337
2016 Gupta S, Zhang J, Rivera M, Erickson LA. Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome. Endocrine Pathology. PMID 27262318 DOI: 10.1007/S12022-016-9439-2  0.317
2016 Sanfrancesco J, McKenney JK, Leivo MZ, Gupta S, Elson P, Hansel DE. Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition. Archives of Pathology & Laboratory Medicine. PMID 27031776 DOI: 10.5858/Arpa.2015-0085-Oa  0.308
2016 Gupta S, Hau AM, Al-Ahmadie HA, Harwalkar J, Shoskes AC, Elson P, Beach JR, Hussey GS, Schiemann WP, Egelhoff TT, Howe PH, Hansel DE. Transforming Growth Factor-β Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion. The American Journal of Pathology. PMID 26988652 DOI: 10.1016/J.Ajpath.2016.01.008  0.307
2015 Gupta S, Naini BV, Munoz R, Graham RP, Kipp BR, Torbenson MS, Mounajjed T. Hepatocellular Neoplasms Arising in Association With Androgen Use. The American Journal of Surgical Pathology. PMID 26685086 DOI: 10.1097/Pas.0000000000000576  0.309
2015 Gupta S, Thompson RH, Boorjian SA, Thapa P, Hernandez LP, Jimenez RE, Costello BA, Frank I, Cheville JC. High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma. Pathology. 47: 533-42. PMID 26308137 DOI: 10.1097/Pat.0000000000000301  0.359
2015 Lohse CM, Gupta S, Cheville JC. Outcome prediction for patients with renal cell carcinoma. Seminars in Diagnostic Pathology. 32: 172-83. PMID 25753528 DOI: 10.1053/J.Semdp.2015.02.008  0.367
2015 Sahu D, Gupta S, Hau AM, Elson P, Bomalaski J, Boss GR, Hansel DE. Abstract 4712: Targeting the arginine-nitric oxide pathway to arrest development and progression of invasive bladder cancer Cancer Research. 75: 4712-4712. DOI: 10.1158/1538-7445.Am2015-4712  0.343
2013 Gupta S, Hau AM, Beach JR, Harwalker J, Mantuano E, Gonias SL, Egelhoff TT, Hansel DE. Mammalian target of rapamycin complex 2 (mTORC2) is a critical determinant of bladder cancer invasion. Plos One. 8: e81081. PMID 24312263 DOI: 10.1371/Journal.Pone.0081081  0.316
2013 Gupta S, Maria M, Bomalaski J, Elson PJ, Singh K, Harwalkar J, Carver P, Almasan A, Hansel DE. Abstract 11: Arginine deprivation therapy using ADI-PEG20 as a novel therapeutic modality in the treatment of bladder cancer. Cancer Research. 73: 11-11. DOI: 10.1158/1538-7445.Am2013-11  0.369
2012 Gupta S, Bomalaski JS, Carver PD, Hansel DE. Abstract 3652: Pegylated arginine deiminase (ADI-PEG20) as a potential therapeutic agent for rarer variants of bladder cancer that are deficient for argininosuccinate synthetase Cancer Research. 72: 3652-3652. DOI: 10.1158/1538-7445.Am2012-3652  0.369
2011 Xu X, Gupta S, Hu W, McGrath BC, Cavener DR. Hyperthermia induces the ER stress pathway. Plos One. 6: e23740. PMID 21876766 DOI: 10.1371/Journal.Pone.0023740  0.602
2010 Cavener DR, Gupta S, McGrath BC. PERK in beta cell biology and insulin biogenesis. Trends in Endocrinology and Metabolism: Tem. 21: 714-21. PMID 20850340 DOI: 10.1016/J.Tem.2010.08.005  0.61
2010 Gupta S, McGrath B, Cavener DR. PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway. Diabetes. 59: 1937-47. PMID 20530744 DOI: 10.2337/Db09-1064  0.605
2009 Gupta S, McGrath B, Cavener DR. PERK regulates the proliferation and development of insulin-secreting beta-cell tumors in the endocrine pancreas of mice. Plos One. 4: e8008. PMID 19956728 DOI: 10.1371/Journal.Pone.0008008  0.615
2009 Feng D, Wei J, Gupta S, McGrath BC, Cavener DR. Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation. Bmc Cell Biology. 10: 61. PMID 19732428 DOI: 10.1186/1471-2121-10-61  0.615
2009 Gupta S, McGrath B, Cavener DR. Correction: PERK Regulates the Proliferation and Development of Insulin-Secreting Beta-Cell Tumors in the Endocrine Pancreas of Mice Plos One. 4. DOI: 10.1371/annotation/b22a2657-7ce6-471a-8593-8bc8e86e2efa  0.581
Show low-probability matches.